Interferons and Natalizumab for Multiple Sclerosis

Multiple sclerosis (MS) is a chronic inflammatory disease of the central nervous system which is accompanied by considerable disability and high costs. This report summarises the evidence on effectiveness and costs of beta-interferons and natalizumab in the treatment of multiple sclerosis. The revie...

Descripción completa

Detalles Bibliográficos
Autores principales: Clar, Christine, Velasco Garrido, Marcial, Gericke, Christian, Busse, Reinhard
Formato: Texto
Lenguaje:English
Publicado: German Medical Science GMS Publishing House 2008
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3011296/
https://www.ncbi.nlm.nih.gov/pubmed/21289915

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3011296/
https://www.ncbi.nlm.nih.gov/pubmed/21289915

Ejemplares similares